Cover Image
市場調查報告書

全球神經修復·再生市場規模,佔有率,趨勢分析:各產品(生醫材料,神經刺激·神經調節設備),手術別,各地區趨勢,市場區隔預測

Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Surgery, By Region, And Segment Forecasts, 2018 - 2024

出版商 Grand View Research, Inc. 商品編碼 639947
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球神經修復·再生市場規模,佔有率,趨勢分析:各產品(生醫材料,神經刺激·神經調節設備),手術別,各地區趨勢,市場區隔預測 Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Surgery, By Region, And Segment Forecasts, 2018 - 2024
出版日期: 2018年04月03日 內容資訊: 英文 110 Pages
簡介

本報告提供全球神經修復·再生市場相關調查,彙整市場現狀與成長預測,各產品,手術別,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 推動市場的要素
    • 阻礙市場的要素
  • 優先的主要機會
  • 產業分析
  • 競爭趨勢
  • PESTEL分析

第4章 各產品預測

  • 市場佔有率
  • 生醫材料
  • 神經刺激·神經調節設備

第5章 手術別預測

  • 市場佔有率
  • 直接神經修復/神經縫合
  • 神經移植
  • 幹細胞治療
  • 神經刺激·神經調節手術

第6章 各地區預測

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • AxoGen, Inc.
  • Baxter International, Inc.
  • Boston Scientific, Inc.
  • St. Jude Medical, Inc.
  • Cyberonics, Inc.
  • Integra Lifesciences Corporation
  • Medtronic plc.
  • Stryker Corporation
  • Polyganics B.V.
目錄
Product Code: 978-1-68038-961-6

The global nerve repair and regeneration market is expected to reach USD 15.7 billion by 2024, according to a new report by Grand View Research Inc. The demand for neurological disorder devices and therapies is expected to upsurge over the forecast period owing to rising awareness, increasing incidence rate, government funding & reimbursement policies, and uninterrupted technological advances by the key players of the industry (nerve control and regeneration technique is a rapidly growing division of neural tissue engineering). It has been estimated that more than 0.8 million people were affected due to nervous system injuries per year.

In January 2016, The EU Horizon 2020 program funded a research project 'Autostem' launched by the NUI Galway's Regenerative Medicine Institute (REMEDI) costing about USD 6.73 million. This project was expected to develop a robotic stem cell production factory, having an edge over the old traditional techniques. Also, this technique will treat a range of therapies pertaining to cancer, diabetes, arthritis and other diseases.

Investment by market players in research & development and commercialization in emerging countries are the major factors to drive the market growth in coming years. For instance, in October 2015, Helius Medical signed an agreement with A&B Company Limited for the development and commercialization of Helius' Portable Neuromodulation Stimulator in Singapore, Taiwan, Hong Kong, Macao, and China. Under this agreement, A&B is expected to acquire certain Asian patents ownership, product support material, and patent applications for the PoNS device.

Further Key Findings From the Study Suggest:

Neurostimulation and neuromodulation devices dominated the product segment of the market in 2015 due to the rising awareness about the devices, coupled with the increasing central nervous system disorders in the population.

Biomaterials segment is anticipated to grow at the fastest rate during the forecast period. This can be attributed to technological advancement, development of biodegradable polymers which are expected to enhance spinal stabilization, healing of fractures, & reduce hospitalization, and rising adoption.

North America dominated the market in 2015 owing to the technological advancements in the region and the introduction of new devices by the manufacturers. In 2015, U.S proved to be the most potential market. Increasing injuries to the central nervous system (CNS), including injuries to the spinal cord and the brain, increased cases, initiatives and funding from governments and various other agencies were some of the major reasons of growth.

According to the report published by the Florida university, more than 2 million people were suffering with traumatic injuries of the brain in the US annually and 5,00,000 people suffered due to the spinal cord injuries. The major causes of CNS injuries result from poorly understood biochemical pathological events.

Also, In March 2016, Baxter completed the CE marking, the indication for marketing of 'HEMOPATCH' the ready-to-use surgical patch in the European market. This patch was approved for use during traumatic injuries of the brain, CNS or other body parts that result in shrinkage of dura mater also, as a hemostatic device to prevent loss of blood or any other body fluid.

Asia Pacific is expected to be the fastest growing region during the forecast period. An aging population, technological advancement and presence of unmet medical needs are some of the reasons for the growth of the market.

In February 2016, Indian scientists working for Revita Life Sciences were approved to conduct clinical trials in 20 clinically dead patients to bring specific parts of their central nervous system back to life. Combination of therapies including cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells and other techniques that were successful in bringing patients out of coma were to be used. Existing medical devices were combined with regenerative biological medicines with an objective to achieve such a complex initiative.

Manufacturers are conducting collaborative exercises by use of innovative devices and therapies to improve the efficiency of treatment and provide better results.

Some key players in this industry include Boston Scientific, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic plc., Baxter International, Inc., AxoGen, Inc., Polyganics B.V., Integra Lifesciences Corporation, and Cyberonics, Inc.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Nerve Repair and Regeneration - Industry snapshot and key buying criteria, 2016 - 2024

Chapter 3. Nerve Repair and Regeneration Industry Outlook

  • 3.1. Nerve repair and regeneration market segmentation
  • 3.2. Nerve repair and regeneration market size and growth prospects, 2016 - 2024
  • 3.3. Nerve repair and regeneration: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increased government funding and recommendations
      • 3.3.1.2. Technological advances and introduction of new therapies by global players of this market.
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Legal issues
      • 3.3.2.2. Higher cost of treatment
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Nerve repair and regeneration: competitive landscape
    • 3.6.1. Competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
  • 3.7. Nerve repair and regeneration PESTEL analysis, 2015
    • 3.7.1 Nerve repair and regeneration technology: Future aspects

Chapter 4. Nerve Repair and Regeneration Product Outlook

  • 4.1. Nerve repair and regeneration market share by product, 2016 & 2024
  • 4.2. Biomaterials
    • 4.2.1. Biomaterials market estimates, 2013 - 2015 (USD Million)
    • 4.2.2. Biomaterials market forecasts, 2016 - 2024 (USD Million)
  • 4.3. Neurostimulation and Neuromodulation Devices
    • 4.3.1. Neurostimulation and neuromodulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.2. Neurostimulation and neuromodulation devices market forecasts, 2016 - 2024 (USD Million)
    • 4.3.3. Spinal cord stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.4. Spinal cord stimulation devices market forecasts, 2016 - 2024 (USD Million)
    • 4.3.5. Deep brain stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.6. Deep brain stimulation devices market forecasts, 2016 - 2024 (USD Million)
    • 4.3.7. Sacral nerve stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.8. Sacral nerve stimulation devices market forecasts, 2016 - 2024 (USD Million)
    • 4.3.9. Vagus nerve stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.10. Vagus nerve stimulation devices market forecasts, 2016 - 2024 (USD Million)
    • 4.3.11. Gastric electric stimulation devices market estimates, 2013 - 2015 (USD Million)
    • 4.3.12. Gastric electric stimulation devices market forecasts, 2016 - 2024 (USD Million)

Chapter 5. Nerve Repair and Regeneration Surgery Outlook

  • 5.1. Nerve repair and regeneration market share by application, 2016 & 2024
  • 5.2. Direct nerve repair/neurorrhaphy
    • 5.2.1. Direct nerve repair/neurorrhaphy market estimates, 2013 - 2015 (USD Million)
    • 5.2.2. Direct nerve repair/neurorrhaphy market forecasts, 2016 - 2024 (USD Million)
  • 5.3. Nerve grafting
    • 5.3.1. Nerve grafting market estimates, 2013 - 2015 (USD Million)
    • 5.3.2. Nerve grafting market forecasts, 2016 - 2024 (USD Million)
  • 5.4. Stem cell therapy
    • 5.4.1. Stem cell therapy market estimates, 2013 - 2015 (USD Million)
    • 5.4.2. Stem cell therapy forecasts, 2016 - 2024 (USD Million)
  • 5.5. Neurostimulation and neuromodulation surgeries
    • 5.5.1. Neurostimulation and neuromodulation surgeries market estimates, 2013 - 2015 (USD Million)
    • 5.5.2. Neurostimulation and neuromodulation surgeries market forecasts, 2016 - 2024 (USD Million)

Chapter 6. Nerve Repair and Regeneration Regional Outlook

  • 6.1. North America
    • 6.1.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
    • 6.1.2. Nerve repair and regeneration market forecasts, by product, 2016 - 2024 (USD Million)
    • 6.1.3. Nerve repair and regeneration market estimates, by surgery, 2013 - 2015 (USD Million)
    • 6.1.4. Nerve repair and regeneration market forecast, by surgery, 2016 - 2024 (USD Million)
      • 6.1.4.1. U.S.
      • 6.1.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.1.4.1.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
      • 6.1.4.2. Canada
      • 6.1.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.1.4.2.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
  • 6.2. Europe
    • 6.2.1. Nerve repair and regeneration market estimates, by product 2013 - 2015 (USD Million)
    • 6.2.2. Nerve repair and regeneration market forecast, by product, 2016 - 2024 (USD Million)
    • 6.2.3. Nerve repair and regeneration market estimates by surgery, 2013 - 2015 (USD Million)
    • 6.2.4. Nerve repair and regeneration market forecast by surgery, 2016 - 2024 (USD Million)
      • 6.2.4.1. UK
      • 6.2.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.2.4.1.2. Nerve repair and regeneration marketforecasts, 2016 - 2024 (USD Million)
      • 6.2.4.2. Germany,
      • 6.2.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.2.4.2.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
      • 6.2.4.3. France
      • 6.2.4.3.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.2.4.3.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
  • 6.3. Asia Pacific
    • 6.3.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
    • 6.3.2. Nerve repair and regeneration market forecasts, by product, 2016 - 2024 (USD Million)
    • 6.3.3. Nerve repair and regeneration market estimates, by application, 2013 - 2016 (USD Million)
    • 6.3.4. Nerve repair and regeneration market forecasts, by application, 2016 - 2024 (USD Million)
      • 6.3.4.1. India
      • 6.3.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.3.4.1.2. Nerve repair and regeneration marketforecasts, 2016 - 2024 (USD Million)
      • 6.3.4.2. China
      • 6.3.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.3.4.2.2. Nerve repair and regeneration marketforecasts, 2016 - 2024 (USD Million)
      • 6.3.4.3. Japan
      • 6.3.4.3.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.3.4.3.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
  • 6.4. Latin America
    • 6.4.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
    • 6.4.2. Nerve repair and regeneration forecasts, by product, 2016 - 2024 (USD Million)
    • 6.4.3. Nerve repair and regeneration market estimates, by surgery, 2013 - 2016 (USD Million)
    • 6.4.4. Nerve repair and regeneration forecasts, by surgery, 2016 - 2024 (USD Million)
      • 6.4.4.1. Brazil
      • 6.4.4.1.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.4.4.1.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
      • 6.4.4.2. Mexico
      • 6.4.4.2.1. Nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.4.4.2.2. Nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)
  • 6.5. MEA
    • 6.5.1. Nerve repair and regeneration market estimates, by product, 2013 - 2015 (USD Million)
    • 6.5.2. Nerve repair and regeneration forecasts, by product, 2016 - 2024 (USD Million)
    • 6.5.3. Nerve repair and regeneration market estimates, by surgery, 2013 - 2016 (USD Million)
    • 6.5.4. Nerve repair and regeneration forecasts, by surgery, 2016 - 2024 (USD Million)
      • 6.5.4.1. South Africa
      • 6.5.4.1.1. South Africa nerve repair and regeneration market estimates, 2013 - 2015 (USD Million)
      • 6.5.4.1.2. South Africa nerve repair and regeneration market forecasts, 2016 - 2024 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. AxoGen, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. Baxter International, Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Boston Scientific, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. St. Jude Medical, Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. Cyberonics, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Financial Performance
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Initiatives
  • 7.6. Integra Lifesciences Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. Medtronic plc.
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. Stryker Corporation
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
  • 7.9. Polyganics B.V.
    • 7.9.1. Company Overview
    • 7.9.2. Financial Performance
    • 7.9.3. Product Benchmarking
    • 7.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Nerve repair and regeneration market - Industry snapshot & key buying criteria, 2013 - 2024
  • TABLE 2 Global nerve repair and regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 3 Global nerve repair and regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 4 Global nerve repair and regeneration market, by region, 2013 - 2024 (USD Million)
  • TABLE 5 Nerve repair and regeneration - Key market driver analysis
  • TABLE 6 Nerve repair and regeneration - Key market restraint analysis
  • TABLE 7 North America nerve repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 8 U.S. nerve repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 9 U.S.nerve repair and regeneration, by surgery, 2013 - 2024 (USD Million)
  • TABLE 10 Canada nerve repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 11 Canada Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 12 Europe Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 13 Europe Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 14 UK Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 15 UK Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 16 Germany Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 17 Germany Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million
  • TABLE 18 Asia Pacific Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 19 Asia Pacific Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 20 Japan Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 21 Japan Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 22 China Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 23 China Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 24 Latin America Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 25 Latin America Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 26 Brazil Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 27 Brazil Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 28 Mexico Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 29 Mexico Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 30 MEA Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 31 MEA Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)
  • TABLE 32 South Africa Nerve Repair and Regeneration market, by product, 2013 - 2024 (USD Million)
  • TABLE 33 South Africa Nerve Repair and Regeneration market, by surgery, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1 Nerve repair and regeneration market segmentation
  • FIG. 2 Global nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 3 Nerve Repair and Regeneration market dynamics
  • FIG. 4 Key opportunities prioritized
  • FIG. 5 Nerve repair and regeneration market Porter's analysis
  • FIG. 6 Nerve repair and regeneration market PESTEL analysis
  • FIG. 7 Nerve repair and regeneration competitive landscape, 2014
  • FIG. 8 Nerve repair and regeneration revenue share, by devices, 2013 - 2024
  • FIG. 9 Biomaterials market, 2013 - 2024 (USD Million)
  • FIG. 10 Neurostimulation and neuromodulation devices market, 2013 - 2024 (USD Million)
  • FIG. 11 Spinal Cord Stimulation Devices market, 2013 - 2024 (USD Million)
  • FIG. 12 Deep Brain Stimulation Devices market, 2013 - 2024 (USD Million)
  • FIG. 13 Sacral Nerve Stimulation Devices market, 2013 - 2024 (USD Million)
  • FIG. 14 Vagus Nerve Stimulation Devices market, 2013 - 2024 (USD Million)
  • FIG. 15 Gastric Electric Stimulation Devices market, 2013 - 2024 (USD Million)
  • FIG. 16 Nerve repair and regeneration revenue, share by surgery, 2013 - 2024
  • FIG. 17 Direct nerve repair/neurorrhaphy market, 2013 - 2024 (USD Million)
  • FIG. 18 Nerve grafting market, 2013 - 2024 (USD Million)
  • FIG. 19 Stem cell therapy market, 2013 - 2024 (USD Million)
  • FIG. 20 Neurostimulation and neuromodulation market, 2013 - 2024 (USD Million)
  • FIG. 21 Nerve repair and regeneration revenue share by region, 2013 & 2024
  • FIG. 22 North America nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 23 US nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 24 Canada nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 25 Europe nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 26 UK nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 27 Germany nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 28 France nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 29 Asia Pacific nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 30 Japan nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 31 China nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 32 India nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 33 Latin America nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 34 Brazil nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 35 Mexico nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 36 MEA nerve repair and regeneration market, 2013 - 2024 (USD Million)
  • FIG. 37 South Africa nerve repair and regeneration market, 2013 - 2024 (USD Million)
Back to Top